Signaling Through gp130 Compromises Suppressive Function in Human FOXP3⁺ Regulatory T Cells

Area of Science:

• Immunology
• Cell Biology

Background:

• CD4+FOXP3+ regulatory T cells (Tregs) are vital for immune tolerance.
• Human Tregs exhibit functional heterogeneity, with some cells showing reduced suppressive capacity despite expressing FOXP3.
• Conventional markers do not distinguish between suppressive and non-suppressive human Tregs.

Purpose of the Study:

• To investigate factors contributing to the loss of suppressive function in human Tregs.
• To identify molecular markers associated with diminished Treg suppressive capacity.
• To explore the role of gp130 signaling in regulating human Treg function.

Main Methods:

• Analysis of FOXP3+ cells and primary FOXP3+ clones.
• Assessment of Treg suppressive capacity ex vivo.
• Measurement of gp130 expression and signaling pathways.
• Evaluation of Helios transcription factor expression.

Main Results:

• High expression of gp130 identifies human Tregs with reduced suppressive capacity.
• IL-6 and IL-27, signaling through gp130, impair human Treg suppressive function.
• gp130 signaling decreases the expression of the transcription factor Helios, crucial for Treg stability.

Conclusions:

• gp130 plays a significant role in regulating the suppressive function of human Tregs.
• gp130 signaling pathway modulation represents a potential therapeutic strategy for manipulating human Treg function.
• Understanding gp130's role offers insights into immune tolerance mechanisms and potential autoimmune disease treatments.